Why the study?
The study was conducted to investigate the impact of arterial stiffness assessed using Cardio-ankle Vascular Index on long-term outcome after acute coronary syndrome.
Does a high Cardio-ankle Vascular Index (CAVI) predict long-term major adverse cardiovascular events in patients with acute coronary syndrome?
Does a high Cardio-ankle Vascular Index (CAVI) predict long-term major adverse cardiovascular events in patients with acute coronary syndrome?
Arterial stiffness assessed by the Cardio-ankle Vascular Index (CAVI) is an independent predictor of long-term MACE and cardiovascular death in ACS patients, providing incremental prognostic value over the GRACE risk score.
High CAVI was associated with higher long-term MACE risk post-ACS; supports hypothesis-generating use in risk stratification but should not yet change practice.
AIM: The purpose of this study is to investigate the impact of arterial stiffness assessed using Cardio-ankle Vascular Index (CAVI) on long-term outcome after acute coronary syndrome (ACS). METHODS: A total of 387 consecutive patients (324 males; age, 64±11 years) with ACS were enrolled. We examined CAVI and brachial-ankle pulse wave velocity (ba PWV) as the parameters of arterial stiffness. The patients were divided into two groups according to the cut-off value of CAVI determined using the receiver operating characteristic curve for the prediction of major adverse cardiovascular events (MACE): low-CAVI group, 177 patients with CAVI <8.35; high-CAVI group, 210 patients with CAVI ≥ 8.35. The primary endpoint was the incidence of MACE (cardiovascular death, recurrence of ACS, heart failure requiring hospitalization, or stroke). RESULTS: A total of 62 patients had MACE. Kaplan-Meier analysis demonstrated a significantly higher probability of MACE in the high-CAVI group than in the low-CAVI group (median follow-up: 62 months; log-rank, p<0.001). Multivariate analysis suggested that CAVI was an independent predictor of MACE (hazard ratio [HR], 1.496; p=0.02) and cardiovascular death (HR, 2.204; p=0.025), but ba PWV was not. We investigated the incremental predictive value of adding CAVI to the GRACE score (GRS), a validated scoring system for risk assessment in ACS. Stratified by CAVI and GRS, a significantly higher rate of MACE was seen in patients with both higher CAVI and higher GRS than the other groups (p<0.001). Furthermore, the addition of CAVI to GRS enhanced net reclassification improvement (NRI) and integrated discrimination improvement (IDI) (NRI, 0.337, p=0.034; and IDI, 0.028, p=0.004). CONCLUSION: CAVI was an independent long-term predictor of MACE, especially cardiovascular death, adding incremental clinical significance for risk stratification in patients with ACS.
No takes yet. Share an insight, caveat, or question.
Kirigaya et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: